Recurrent Non-Small Cell Lung Carcinoma
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| erlotinib | CG Oncology, Inc. (CGON) |
Frequently asked questions
How many drugs are in development for Recurrent Non-Small Cell Lung Carcinoma?
BioSniper tracks 1 drug in development for Recurrent Non-Small Cell Lung Carcinoma across 1 company.
How many clinical trials target Recurrent Non-Small Cell Lung Carcinoma?
There are 2 clinical trials targeting Recurrent Non-Small Cell Lung Carcinoma tracked by BioSniper.
Deep-dive into Recurrent Non-Small Cell Lung Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis